Pall launches Kleenpak Presto sterile connectors for genderless fluid transfer applications
Can be used in a wide range of applications in upstream, downstream, and formulation and filling.
Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, has launched the Kleenpak Presto sterile connector to be used in a wide range of applications in upstream, downstream, and formulation and filling.
“We launched the Presto genderless sterile connector family in direct response to customer demand for a reliable, robust universal single-use fluid handling solution,” said the company’s President of Single Use Technologies, Mario Philips. “With its intuitive operation and easy to use features, we worked closely on this new generation design with our customers to ensure even greater levels of sterility assurance.”
The Kleenpak Presto sterile connector is a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments. The connectors are available in ¼ in., ⅜ in., ½ in. and ⅝ in. hose barb sizes, and with ½ in. sanitary connections, and are made from Bisphenol-A free polyethersulfone. The connectors can be used for a wide range of applications and are 100% inspected at point of manufacturer with device traceability and serialization linked to this 100% quality control process.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.